- Home
- ENLT vs FMS Comparison
ENLT vs FMS Comparison
Compare ENLT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLT | FMS |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | Israel | Germany |
| Employees | N/A | 108165 |
| Industry | | Misc Health and Biotechnology Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 13.0B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENLT | FMS |
|---|---|---|
| Price | $83.27 | $25.89 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $48.83 | $30.00 |
| AVG Volume (30 Days) | 167.8K | ★ 535.2K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $403.69 | N/A |
| Revenue Next Year | N/A | $3.83 |
| P/E Ratio | $76.10 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.95 | $20.02 |
| 52 Week High | $108.65 | $27.64 |
Technical Indicators
Market Signals| Indicator | ENLT | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 74.27 |
| Support Level | $81.35 | $22.47 |
| Resistance Level | $93.00 | $27.40 |
| Average True Range (ATR) | 3.49 | 0.35 |
| MACD | -0.48 | 0.12 |
| Stochastic Oscillator | 20.17 | 85.46 |
Price Performance
Historical ComparisonAbout ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.